Obstet Gynecol Sci.  2023 May;66(3):149-160. 10.5468/ogs.23001.

Pregnancy and COVID-19: past, present and future

• Kim YK
• Kim EH

• KMID: 2542221
• DOI: http://doi.org/10.5468/ogs.23001

Abstract

Current evidence suggests that severe acute respiratory syndrome coronavirus 2 infection is associated with an increased incidence of adverse severe maternal and perinatal outcomes. However, vertical transmission is rare. The management of pregnant women with coronavirus disease 2019 (COVID-19) is similar to that of non-pregnant women, and effective treatments, including antiviral therapy, dexamethasone, and prophylactic anticoagulation should not be withheld during pregnancy. During the early COVID-19 pandemic period, the management of pregnant women was often delayed until the polymerase chain reaction (PCR) results came out or due to close contact, even among those without symptoms. Out of concern for the spread of infection, cesarean sections were performed instead of vaginal birth, since infection could have led to an increase in maternal and neonatal morbidities. Additionally, if the maternal PCR test was positive, the neonate was quarantined, and despite infectivity decreasing 10 days after symptom onset. It is necessary to ease the strict measures of infection control in the field of obstetrics. The presence or absence of maternal COVID-19 symptoms should be identified to stratify the risk, and vaginal delivery can be attempted in asymptomatic women with low infectivity. With more women being vaccinated safety data about vaccination is rapidly accumulating and no concerns have been detected. Globally, COVID-19 vaccines are recommended even during pregnancy. In order to prepare for future pandemics, it is necessary to apply lessons learned from this pandemic. Policymakers and healthcare leaders must determine efficient and effective strategies for preserving safe maternal care, even during an ongoing global emergency.

Keyword

Pregnancy; COVID-19; Severe acute respiratory syndrome coronavirus 2; Risk factors; Vertical infection transmission

Reference

References

1. Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020; 324:782–93.

2. Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med. 2014; 370:2211–8.

3. Robinson DP, Klein SL. Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav. 2012; 62:263–71.

4. Pazos M, Sperling RS, Moran TM, Kraus TA. The influence of pregnancy on systemic immunity. Immunol Res. 2012; 54:254–61.

5. Badr DA, Picone O, Bevilacqua E, Carlin A, Meli F, Sibiude J, et al. Severe acute respiratory syndrome coronavirus 2 and pregnancy outcomes according to gestational age at time of infection. Emerg Infect Dis. 2021; 27:2535–43.

6. Metz TD, Clifton RG, Hughes BL, Sandoval G, Saade GR, Grobman WA, et al. Disease severity and perinatal outcomes of pregnant patients with coronavirus disease 2019 (COVID-19). Obstet Gynecol. 2021; 137:571–80.

7. Vousden N, Bunch K, Morris E, Simpson N, Gale C, O’Brien P, et al. The incidence, characteristics and outcomes of pregnant women hospitalized with symptomatic and asymptomatic SARS-CoV-2 infection in the UK from March to September 2020: a national cohort study using the UK Obstetric Surveillance System (UKOSS). PLoS One. 2021; 16:e0251123.

8. LoMauro A, Aliverti A. Respiratory physiology of pregnancy: physiology masterclass. Breathe (Sheff). 2015; 11:297–301.

9. Liu D, Li L, Wu X, Zheng D, Wang J, Yang L, et al. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: a preliminary analysis. AJR Am J Roentgenol. 2020; 215:127–32.

10. Callaghan WM, Creanga AA, Jamieson DJ. Pregnancy-related mortality resulting from influenza in the United States during the 2009–2010 pandemic. Obstet Gynecol. 2015; 126:486–90.

11. Rogers VL, Sheffield JS, Roberts SW, McIntire DD, Luby JP, Trevino S, et al. Presentation of seasonal influenza a in pregnancy: 2003–2004 influenza season. Obstet Gynecol. 2010; 115:924–9.

12. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382:1708–20.

13. Vintzileos WS, Muscat J, Hoffmann E, John NS, Vertichio R, Vintzileos AM, et al. Screening all pregnant women admitted to labor and delivery for the virus responsible for coronavirus disease 2019. Am J Obstet Gynecol. 2020; 223:284–6.

14. Jamieson DJ, Rasmussen SA. An update on COVID-19 and pregnancy. Am J Obstet Gynecol. 2022; 226:177–86.

15. Hantoushzadeh S, Shamshirsaz AA, Aleyasin A, Seferovic MD, Aski SK, Arian SE, et al. Maternal death due to COVID-19. Am J Obstet Gynecol. 2020; 223:109e1–109.e16.

16. Panagiotakopoulos L, Myers TR, Gee J, Lipkind HS, Kharbanda EO, Ryan DS, et al. SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics - eight U.S. health care centers, March 1–May 30, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69:1355–9.

17. Lokken EM, Walker CL, Delaney S, Kachikis A, Kretzer NM, Erickson A, et al. Clinical characteristics of 46 pregnant women with a severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am J Obstet Gynecol. 2020; 223:911.e1–911.e14.

18. Knight M, Bunch K, Vousden N, Morris E, Simpson N, Gale C, et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020; 369:m2107.

19. World Health Organization (WHO). WHO coronavirus (COVID-19) dashboard 2020 [Internet]. Geneva: WHO;c2023. [cited 2023 Feb 16]. Available from https://covid19.who.int/?adgroupsurvey={adgroupsurvey}&gclid=Cj0KCQiAorKfBhC0ARIsAHDzslvJeSjvjqIqXUxEoHB6Njbj7VABhDB7G2yJmrj0VUrkWOlj6y4xaewaAh-VEALw_wcB .

20. Oran DP, Topol EJ. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann Intern Med. 2020; 173:362–7.

21. Buitrago-Garcia D, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Ipekci AM, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: a living systematic review and meta-analysis. PLoS Med. 2020; 17:e1003346.

22. Lee Y, Yoon JS, Kim YK, Kim EH. Clinical manifestations and maternal and perinatal outcomes in pregnancy following laboratory-confirmed SARS-CoV-2 infection in South Korea. J Korean Soc Matern Child Health. 2022; 26:104–11.

23. Shook LL, Brigida S, Regan J, Flynn JP, Mohammadi A, Etemad B, et al. SARS-CoV-2 placentitis associated with B.1.617.2 (Delta) variant and fetal distress or demise. J Infect Dis. 2022; 225:754–8.

24. Lokken EM, Huebner EM, Taylor GG, Hendrickson S, Vanderhoeven J, Kachikis A, et al. Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State. Am J Obstet Gynecol. 2021; 225:77e1–77.e14.

25. Zambrano LD, Ellington S, Strid P, Galang RR, Oduyebo T, Tong VT, et al. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22–October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69:1641–7.

26. Magnus MC, Oakley L, Gjessing HK, Stephansson O, Engjom HM, Macsali F, et al. Pregnancy and risk of COVID-19: a Norwegian registry-linkage study. BJOG. 2022; 129:101–9.

27. McClymont E, Albert AY, Alton GD, Boucoiran I, Castillo E, Fell DB, et al. Association of SARS-CoV-2 infection during pregnancy with maternal and perinatal outcomes. JAMA. 2022; 327:1983–91.

28. Golan Y, Prahl M, Cassidy AG, Gay C, Wu AHB, Jigmeddagva U, et al. COVID-19 mRNA vaccination in lactation: assessment of adverse events and vaccine related antibodies in mother-infant dyads. Front Immunol. 2021; 12:777103.

29. Jacoby VL, Murtha A, Afshar Y, Gaw SL, Asiodu I, Tolosa J, et al. Risk of pregnancy loss before 20 weeks’ gestation in study participants with COVID-19. Am J Obstet Gynecol. 2021; 225:456–7.

30. Galang RR, Newton SM, Woodworth KR, Griffin I, Oduyebo T, Sancken CL, et al. Risk factors for illness severity among pregnant women with confirmed severe acute respiratory syndrome coronavirus 2 infection-surveillance for emerging threats to mothers and babies network, 22 state, local, and territorial health departments, 29 March 2020–5 March 2021. Clin Infect Dis. 2021; 73:S17–23.

31. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ. 2020; 370:m3320.

32. Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ. 2021; 193:E540–8.

33. Di Mascio D, Khalil A, Saccone G, Rizzo G, Buca D, Liberati M, et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020; 2:100107.

34. Marchand G, Patil AS, Masoud AT, Ware K, King A, Ruther S, et al. Systematic review and meta-analysis of COVID-19 maternal and neonatal clinical features and pregnancy outcomes up to June 3, 2021. AJOG Glob Rep. 2022; 2:100049.

35. Mullins E, Hudak ML, Banerjee J, Getzlaff T, Townson J, Barnette K, et al. Pregnancy and neonatal outcomes of COVID-19: coreporting of common outcomes from PAN-COVID and AAP-SONPM registries. Ultrasound Obstet Gynecol. 2021; 57:573–81.

36. Jering KS, Claggett BL, Cunningham JW, Rosenthal N, Vardeny O, Greene MF, et al. Clinical characteristics and outcomes of hospitalized women giving birth with and without COVID-19. JAMA Intern Med. 2021; 181:714–7.

37. Woodworth KR, Olsen EO, Neelam V, Lewis EL, Galang RR, Oduyebo T, et al. Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy-SET-NET, 16 jurisdictions, March 29–October 14, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69:1635–40.

38. Centers for Disease Control and Prevention. Vital statistics rapid release births: provisional data for 2018 [Internet]. Atlanta (GA): Centers for Disease Control and Prevention;c2018. [cited 2023 Mar 27]. Available from: https://www.cdc.gov/nchs/data/vsrr/vsrr012-508.pdf .

39. Katz D, Bateman BT, Kjaer K, Turner DP, Spence NZ, Habib AS, et al. The society for obstetric anesthesia and perinatology coronavirus disease 2019 registry: an analysis of outcomes among pregnant women delivering during the initial severe acute respiratory syndrome coronavirus-2 outbreak in the United States. Anesth Analg. 2021; 133:462–73.

40. Pierce-Williams RAM, Burd J, Felder L, Khoury R, Bernstein PS, Avila K, et al. Clinical course of severe and critical coronavirus disease 2019 in hospitalized pregnancies: a United States cohort study. Am J Obstet Gynecol MFM. 2020; 2:100134.

41. Smith LH, Dollinger CY, VanderWeele TJ, Wyszynski DF, Hernández-Díaz S. Timing and severity of COVID-19 during pregnancy and risk of preterm birth in the international registry of coronavirus exposure in pregnancy. BMC Pregnancy Childbirth. 2022; 22:775.

42. Shah PS, Ye XY, Yang J, Campitelli MA. Preterm birth and stillbirth rates during the COVID-19 pandemic: a population-based cohort study. CMAJ. 2021; 193:E1164–72.

43. Chmielewska B, Barratt I, Townsend R, Kalafat E, van der Meulen J, Gurol-Urganci I, et al. Effects of the COVID-19 pandemic on maternal and perinatal outcomes: a systematic review and meta-analysis. Lancet Glob Health. 2021; 9:e759–72.

44. Been JV, Burgos Ochoa L, Bertens LCM, Schoenmakers S, Steegers EAP, Reiss IKM. Impact of COVID-19 mitigation measures on the incidence of preterm birth: a national quasi-experimental study. Lancet Public Health. 2020; 5:e604–11.

45. Harvey EM, McNeer E, McDonald MF, Shapiro-Mendoza CK, Dupont WD, Barfield W, et al. Association of preterm birth rate with COVID-19 statewide stay-at-home orders in tennessee. JAMA Pediatr. 2021; 175:635–7.

46. Villar J, Ariff S, Gunier RB, Thiruvengadam R, Rauch S, Kholin A, et al. Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study. JAMA Pediatr. 2021; 175:817–26.

47. Allotey J, Chatterjee S, Kew T, Gaetano A, Stallings E, Fernández-García S, et al. SARS-CoV-2 positivity in offspring and timing of mother-to-child transmission: living systematic review and meta-analysis. BMJ. 2022; 376:e067696.

48. Kirtsman M, Diambomba Y, Poutanen SM, Malinowski AK, Vlachodimitropoulou E, Parks WT, et al. Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection. CMAJ. 2020; 192:E647–50.

49. Vivanti AJ, Vauloup-Fellous C, Prevot S, Zupan V, Suffee C, Do Cao J, et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun. 2020; 11:3572.

50. Jeganathan K, Paul AB. Vertical transmission of SARS-CoV-2: a systematic review. Obstet Med. 2022; 15:91–8.

51. Unicef Office of Research-Innocenti. The evolving epidemiologic and clinical picture of SARS-CoV-2 and COVID-19 disease in children and young people [Internet]. New York (NY): Unicef Office of Research-Innocenti;c2020. [cited 2023 Mar 27]. Available from: https://www.unicef-irc.org/publications/pdf/Evolving-Epidemiologic-Clinical-Picture-SARS-CoV2-COVID-19-Children-Young-People.pdf .

52. Edlow AG, Li JZ, Collier AY, Atyeo C, James KE, Boatin AA, et al. Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic. JAMA Netw Open. 2020; 3:e2030455.

53. Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020; 323:1843–4.

54. Wong YP, Khong TY, Tan GC. The effects of COVID-19 on placenta and pregnancy: what do we know so far? Diagnostics (Basel). 2021; 11:94.

55. Chambers C, Krogstad P, Bertrand K, Contreras D, Tobin NH, Bode L, et al. Evaluation for SARS-CoV-2 in breast milk from 18 infected women. JAMA. 2020; 324:1347–8.

56. Salvatore CM, Han JY, Acker KP, Tiwari P, Jin J, Brandler M, et al. Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study. Lancet Child Adolesc Health. 2020; 4:721–7.

57. American College of Obstetricians and Gynecologists. COVID-19 FAQs for obstetrician-gynecologists, obstetrics [Internet]. Washington, DC: ACOG;c2020. [cited 2023 Mar 27]. Available from https://www.acog.org/clinicalinformation/physician-faqs/covid-19-faqs-for-ob-gynsobstetrics .

58. Centers for Disease Control and Prevention. Evaluation and management considerations for neonates at risk for COVID-19 [Internet]. Atlanta: Centers for Disease Control and Prevention;c2020. [cited 2023 Mar 27]. Available from: https://stacks.cdc.gov/view/cdc/88194 .

59. Vousden N, Ramakrishnan R, Bunch K, Morris E, Simpson N, Gale C, et al. Impact of SARS-CoV-2 variant on the severity of maternal infection and perinatal outcomes: data from the UK obstetric surveillance system national cohort. MedRxiv. 2021; 2021:21261000.

60. National Institutes of Health. Coronavirus disease 2019 (COVID-19) treatment guidelines [Internet]. Bethesda: National Institutes of Health;c2022. [cited 2022 Sep 26]. Available from: https://www.covid19treatmentguidelines.nih.gov/ .

61. American College of Obstetricians and Gynecologists. COVID-19 vaccination considerations for obstetric-gynecologic care. Practice advisory 2020 [Internet]. Washington, DC: ACOG;c2022. [cited 2022 Sep 26]. Available from: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/covid-19-vaccination-considerations-for-obstetric-gynecologic-care .

62. James JL, Stone PR, Chamley LW. The regulation of trophoblast differentiation by oxygen in the first trimester of pregnancy. Hum Reprod Update. 2006; 12:137–44.

63. Jensen GM, Moore LG. The effect of high altitude and other risk factors on birthweight: independent or interactive effects? Am J Public Health. 1997; 87:1003–7.

64. Tapanainen PJ, Bang P, Wilson K, Unterman TG, Vreman HJ, Rosenfeld RG. Maternal hypoxia as a model for intrauterine growth retardation: effects on insulin-like growth factors and their binding proteins. Pediatr Res. 1994; 36:152–8.

65. Shanes ED, Mithal LB, Otero S, Azad HA, Miller ES, Goldstein JA. Placental pathology in COVID-19. Am J Clin Pathol. 2020; 154:23–32.

66. Glynn SM, Yang YJ, Thomas C, Friedlander RL, Cagino KA, Matthews KC, et al. SARS-CoV-2 and placental pathology: malperfusion patterns are dependent on timing of infection during pregnancy. Am J Surg Pathol. 2022; 46:51–7.

67. Dashraath P, Wong JLJ, Lim MXK, Lim LM, Li S, Biswas A, et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020; 222:521–31.

68. DeSisto CL, Wallace B, Simeone RM, Polen K, Ko JY, Meaney-Delman D, et al. Risk for stillbirth among women with and without COVID-19 at delivery hospitalization - united states, March 2020–September 2021. MMWR Morb Mortal Wkly Rep. 2021; 70:1640–45.

69. Srivastava K. Covid-19: why has India had a spike in stillbirths? BMJ. 2021; 374:n2133.

70. Hernández-Díaz S, Smith LH, Wyszynski DF, Rasmussen SA. First trimester COVID-19 and the risk of major congenital malformations-International registry of coronavirus exposure in pregnancy. Birth Defects Res. 2022; 114:906–14.

71. Kachikis A, Englund JA, Singleton M, Covelli I, Drake AL, Eckert LO. Short-term reactions among pregnant and lactating individuals in the first wave of the COVID-19 vaccine rollout. JAMA Netw Open. 2021; 4:e2121310.

72. Perl SH, Uzan-Yulzari A, Klainer H, Asiskovich L, Youngster M, Rinott E, et al. SARS-CoV-2-specific antibodies in breast milk after COVID-19 vaccination of breastfeeding women. JAMA. 2021; 325:2013–4.

73. Young BE, Seppo AE, Diaz N, Rosen-Carole C, Nowak-Wegrzyn A, Cruz Vasquez JM, et al. Association of human milk antibody induction, persistence, and neutralizing capacity with SARS-CoV-2 infection vs mRNA vaccination. JAMA Pediatr. 2022; 176:159–68.

74. Goldshtein I, Nevo D, Steinberg DM, Rotem RS, Gorfine M, Chodick G, et al. Association between BNT162b2 vaccination and incidence of SARS-CoV-2 infection in pregnant women. JAMA. 2021; 326:728–35.

75. Eid J, Abdelwahab M, Williams H, Caplan M, Hajmurad S, Venkatesh KK, et al. Decreased severity of COVID-19 in vaccinated pregnant individuals during predominance of different SARS-CoV-2 variants. Am J Reprod Immunol. 2022; 88:e13596.

76. Kim H, Kim HS, Kim HM, Kim MJ, Kwon KT, Cha HH, et al. Impact of vaccination and the omicron variant on COVID-19 severity in pregnant women. Am J Infect Control. 2023; 51:351–3.

77. Prabhu M, Murphy EA, Sukhu AC, Yee J, Singh S, Eng D, et al. Antibody response to coronavirus disease 2019 (COVID-19) messenger RNA vaccination in pregnant women and transplacental passage into cord blood. Obstet Gynecol. 2021; 138:278–80.

78. Zauche LH, Wallace B, Smoots AN, Olson CK, Oduyebo T, Kim SY, et al. Receipt of mRNA Covid-19 vaccines and risk of spontaneous abortion. N Engl J Med. 2021; 385:1533–5.

79. Kharbanda EO, Haapala J, DeSilva M, Vazquez-Benitez G, Vesco KK, Naleway AL, et al. Spontaneous abortion following COVID-19 vaccination during pregnancy. JAMA. 2021; 326:1629–31.

80. Lipkind HS, Vazquez-Benitez G, DeSilva M, Vesco KK, Ackerman-Banks C, Zhu J, et al. Receipt of COVID-19 vaccine during pregnancy and preterm or small-for-gestational-age at birth - eight integrated health care organizations, United States, December 15, 2020–July 22, 2021. MMWR Morb Mortal Wkly Rep. 2022; 71:26–30.

81. Sadarangani M, Soe P, Shulha HP, Valiquette L, Vanderkooi OG, Kellner JD, et al. Safety of COVID-19 vaccines in pregnancy: a Canadian National Vaccine Safety (CANVAS) Network cohort study. Lancet Infect Dis. 2022; 22:1553–64.

82. Ahn KH, Kim HI, Lee KS, Heo JS, Kim HY, Cho GJ, et al. COVID-19 and vaccination during pregnancy: a systematic analysis using Korea National Health Insurance claims data. Obstet Gynecol Sci. 2022; 65:487–501.

83. Magnus MC, Gjessing HK, Eide HN, Wilcox AJ, Fell DB, Håberg SE. Covid-19 vaccination during pregnancy and first-trimester miscarriage. N Engl J Med. 2021; 385:2008–10.

84. Ruderman RS, Mormol J, Trawick E, Perry MF, Allen EC, Millan D, et al. Association of COVID-19 vaccination during early pregnancy with risk of congenital fetal anomalies. JAMA Pediatr. 2022; 176:717–9.

85. American College of Obstetrics and Gynecologist. Maternal immunization [Internet]. Washington, DC: American College of Obstetricians and Gynecologist;c2022. [cited 2023 Mar 27]. Available from: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2022/10/maternal-immunization?utm_source=higher-logic&utm_medium=email&utm_content=oct-5&utm_campaign=acog2022-digest .

86. Rottenstreich A, Zarbiv G, Oiknine-Djian E, Vorontsov O, Zigron R, Kleinstern G, et al. The effect of gestational age at BNT162b2 mRNA vaccination on maternal and neonatal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody levels. Clin Infect Dis. 2022; 75:e603–10.

87. Yang YJ, Murphy EA, Singh S, Sukhu AC, Wolfe I, Adurty S, et al. Association of gestational age at coronavirus disease 2019 (COVID-19) vaccination, history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and a vaccine booster dose with maternal and umbilical cord antibody levels at delivery. Obstet Gynecol. 2022; 139:373–80.

88. Martínez-Perez O, Vouga M, Cruz Melguizo S, Forcen Acebal L, Panchaud A, Muñoz-Chápuli M, et al. Association between mode of delivery among pregnant women with COVID-19 and maternal and neonatal outcomes in Spain. JAMA. 2020; 324:296–9.

89. Liu S, Liston RM, Joseph KS, Heaman M, Sauve R, Kramer MS, et al. Maternal mortality and severe morbidity associated with low-risk planned cesarean delivery versus planned vaginal delivery at term. CMAJ. 2007; 176:455–60.

90. Rottenstreich A, Zarbiv G, Oiknine-Djian E, Zigron R, Wolf DG, Porat S. Efficient maternofetal transplacental transfer of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike antibodies after antenatal SARS-CoV-2 BNT162b2 messenger RNA vaccination. Clin Infect Dis. 2021; 73:1909–12.

91. Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. 2021; 384:2273–82.

92. Phillips N. The coronavirus is here to stay - here’s what that means. Nature. 2021; 590:382–4.